Withdrawal Of Atrioventricular Nodal Blocking Agents in Patients Receiving Mavacamten: A Retrospective Single-Center Experience in A Predominantly Asian-American Cohort.

Benavente, Kevin; Moreno, Jesus Pino; Banerjee, Dipanjan

Benavente, Kevin; Moreno, Jesus Pino; Banerjee, Dipanjan.

Afiliação

Benavente K; Department of Medicine, The John A. Burns School of Medicine, University of Hawai'i, Honolulu, Hawaii.
Moreno JP; Department of Medicine, The John A. Burns School of Medicine, University of Hawai'i, Honolulu, Hawaii.
Banerjee D; Department of Medicine, The John A. Burns School of Medicine, University of Hawai'i, Honolulu, Hawaii. Electronic address: dipanjan@hawaii.edu.

Am J Cardiol ; 216: 63-65, 2024 Apr 01.

Article em En | MEDLINE | ID: mdl-38008348

Assuntos

Bloqueio Atrioventricular; Cardiomiopatia Hipertrófica; Uracila/análogos & derivados; Humanos; Estudos Retrospectivos; Benzilaminas

Palavras-chave

AVN blocking agents; hypertrophic cardiomyopathy; mavacamten; myosin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Uracila / Cardiomiopatia Hipertrófica / Bloqueio Atrioventricular Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google